BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37846648)

  • 1. Critical incidents, nocturnal supervision, and caregiver knowledge on SUDEP in patients with Dravet syndrome: A prospective multicenter study in Germany.
    Maltseva M; Rosenow F; Schubert-Bast S; Flege S; Wolff M; von Spiczak S; Trollmann R; Syrbe S; Ruf S; Polster T; Neubauer BA; Mayer T; Jacobs J; Kurlemann G; Kluger G; Klotz KA; Kieslich M; Kay L; Hornemann F; Bettendorf U; Bertsche A; Bast T; Strzelczyk A
    Epilepsia; 2024 Jan; 65(1):115-126. PubMed ID: 37846648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in Germany.
    Maltseva M; Schubert-Bast S; Zöllner JP; Bast T; Mayer T; von Spiczak S; Ruf S; Trollmann R; Wolff M; Hornemann F; Klotz KA; Jacobs J; Kurlemann G; Neubauer BA; Polster T; Syrbe S; Bertsche A; Bettendorf U; Kluger G; Flege S; Rosenow F; Kay L; Strzelczyk A
    Orphanet J Rare Dis; 2023 Apr; 18(1):98. PubMed ID: 37120555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).
    Maguire MJ; Jackson CF; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD011792. PubMed ID: 32239759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge of sudden unexpected death in epilepsy (SUDEP) among 372 patients attending a German tertiary epilepsy center.
    Surges R; von Wrede R; Porschen T; Elger CE
    Epilepsy Behav; 2018 Mar; 80():360-364. PubMed ID: 29454605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).
    Maguire MJ; Jackson CF; Marson AG; Nolan SJ
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011792. PubMed ID: 27434597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in Dravet syndrome.
    Cooper MS; Mcintosh A; Crompton DE; McMahon JM; Schneider A; Farrell K; Ganesan V; Gill D; Kivity S; Lerman-Sagie T; McLellan A; Pelekanos J; Ramesh V; Sadleir L; Wirrell E; Scheffer IE
    Epilepsy Res; 2016 Dec; 128():43-47. PubMed ID: 27810515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome.
    Cross JH; Galer BS; Gil-Nagel A; Devinsky O; Ceulemans B; Lagae L; Schoonjans AS; Donner E; Wirrell E; Kothare S; Agarwal A; Lock M; Gammaitoni AR
    Seizure; 2021 Dec; 93():154-159. PubMed ID: 34768178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany.
    Strzelczyk A; Kalski M; Bast T; Wiemer-Kruel A; Bettendorf U; Kay L; Kieslich M; Kluger G; Kurlemann G; Mayer T; Neubauer BA; Polster T; Herting A; von Spiczak S; Trollmann R; Wolff M; Irwin J; Carroll J; Macdonald D; Pritchard C; Klein KM; Rosenow F; Schubert-Bast S
    Eur J Paediatr Neurol; 2019 May; 23(3):392-403. PubMed ID: 30871879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany.
    Strzelczyk A; Schubert-Bast S; Bast T; Bettendorf U; Fiedler B; Hamer HM; Herting A; Kalski M; Kay L; Kieslich M; Klein KM; Kluger G; Kurlemann G; Mayer T; Neubauer BA; Polster T; von Spiczak S; Stephani U; Trollmann R; Wiemer-Kruel A; Wolff M; Irwin J; Carroll J; Pritchard C; Rosenow F
    Epilepsia; 2019 Aug; 60(8):1697-1710. PubMed ID: 31247127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, longitudinal, multicenter study on the provision of information regarding sudden unexpected death in epilepsy to adults with epilepsy.
    Wadle NE; Schwab C; Seifart C; von Podewils F; Knake S; Willems LM; Menzler K; Schulz J; Conradi N; Rosenow F; Strzelczyk A
    Epilepsia; 2023 Feb; 64(2):406-419. PubMed ID: 36546828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure-related complication rate in a residential population with epilepsy and intellectual disability (ECOMRAID-trial).
    Monté CPJA; Arends JBAM; Lazeron RHC; Tan IY; Boon PAJM
    Epilepsy Behav; 2023 Mar; 140():108995. PubMed ID: 36822042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can We Prevent Sudden Unexpected Death in Epilepsy (SUDEP)?
    Bhasin H; Sharma S; Ramachandrannair R
    Can J Neurol Sci; 2021 Jul; 48(4):464-468. PubMed ID: 33023683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From unwitnessed fatality to witnessed rescue: Nonpharmacologic interventions in sudden unexpected death in epilepsy.
    Rugg-Gunn F; Duncan J; Hjalgrim H; Seyal M; Bateman L
    Epilepsia; 2016 Jan; 57 Suppl 1():26-34. PubMed ID: 26749014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden unexpected death in epilepsy (SUDEP): Definition, epidemiology, and significance of education.
    Mesraoua B; Tomson T; Brodie M; Asadi-Pooya AA
    Epilepsy Behav; 2022 Jul; 132():108742. PubMed ID: 35623204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of epilepsy patients and caregivers who either have or have not heard of SUDEP.
    Kroner BL; Wright C; Friedman D; Macher K; Preiss L; Misajon J; Devinsky O
    Epilepsia; 2014 Oct; 55(10):1486-94. PubMed ID: 25323807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies.
    Donnan AM; Schneider AL; Russ-Hall S; Churilov L; Scheffer IE
    Neurology; 2023 Apr; 100(16):e1712-e1722. PubMed ID: 36750385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUDEP: Living with the knowledge.
    Whitney R; Strohm S; Jeffs T; Jones KC; Jack SM; RamachandranNair R
    Epilepsy Res; 2023 Aug; 194():107177. PubMed ID: 37295320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To reveal or conceal? Adult patient perspectives on SUDEP disclosure.
    Long L; Cotterman-Hart S; Shelby J
    Epilepsy Behav; 2018 Sep; 86():79-84. PubMed ID: 30001909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome.
    Nabbout R; Auvin S; Chiron C; Irwin J; Mistry A; Bonner N; Williamson N; Bennett B
    Epilepsy Behav; 2018 Jan; 78():232-242. PubMed ID: 29108913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life-span characterization of epilepsy and comorbidities in Dravet syndrome mice carrying a targeted deletion of exon 1 of the Scn1a gene.
    Gerbatin RR; Augusto J; Boutouil H; Reschke CR; Henshall DC
    Exp Neurol; 2022 Aug; 354():114090. PubMed ID: 35487274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.